Holen Sie sich die Stockscreener-App
805.37
2.93%
-24.33
Handel nachbörslich:
805.60
0.23
+0.03%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$829.70
Offen:
$835.39
24-Stunden-Volumen:
1.48M
Relative Volume:
2.03
Marktkapitalisierung:
$99.40B
Einnahmen:
$387.09B
Nettoeinkommen (Verlust:
$4.23B
KGV:
25.07
EPS:
32.1208
Netto-Cashflow:
$6.01B
1W Leistung:
-8.86%
1M Leistung:
-1.82%
6M Leistung:
+12.66%
1J Leistung:
+30.33%
1-Tages-Spanne:
$802.72
$835.39
1-Wochen-Bereich:
$802.72
$888.34
52-Wochen-Spanne:
$558.13
$895.58
Mckesson Corporation Stock (MCK) Company Profile
Firmenname
Mckesson Corporation
Sektor
Branche
Telefon
972-446-4800
Adresse
6555 STATE HIGHWAY 161, IRVING, TX
Vergleichen Sie MCK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
805.37 | 102.41B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
335.31 | 68.03B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
199.71 | 48.74B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
72.88 | 8.44B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.39 | 790.85M | 2.22M | -5.63M | -1.68M | -0.24 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-04 | Fortgesetzt | Mizuho | Neutral |
| 2024-11-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | Bestätigt | Leerink Partners | Outperform |
| 2024-08-08 | Bestätigt | Mizuho | Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-07-06 | Herabstufung | Argus | Buy → Hold |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | Bestätigt | Barclays | Overweight |
| 2021-11-02 | Bestätigt | BofA Securities | Buy |
| 2021-11-02 | Bestätigt | Evercore ISI | Outperform |
| 2021-11-02 | Bestätigt | Jefferies | Buy |
| 2021-03-30 | Hochstufung | Argus | Hold → Buy |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-08-04 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-05-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-18 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-13 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-05 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-07-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-02 | Bestätigt | Mizuho | Neutral |
| 2018-01-24 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Mckesson Corporation Aktie (MCK) Neueste Nachrichten
McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025 - ts2.tech
McKesson Corporation: How Are They Benefitting From The GLP-1 Demand Tailwinds? - Smartkarma
McKesson Corporation pushes for biopharma collaboration in cancer care - Traders Union
McKesson’s Advancing Community Oncology Report Charts a New Era of Innovation for Biopharma and Community Care - 01net
Is McKesson Corporation Stock Outperforming the S&P 500? - MSN
McKesson Corporation (NYSE:MCK) Shares Could Be 37% Below Their Intrinsic Value Estimate - Yahoo Finance
Mckesson (NYSE:MCK), Align (NASDAQ:ALGN) Move on Volatility - Kalkine Media
McKesson Corporation: - MarketScreener
McKesson (MCK) Stock Near Record High as Big Money Moves In – Latest News and Outlook on November 29, 2025 - ts2.tech
Why McKesson Corporation (MCK) stock attracts HNW investorsWeekly Stock Summary & Weekly Watchlist for Hot Stocks - moha.gov.vn
Ex-Dividend Reminder: McKesson, Universal Health Services and Concentra Group Holdings Parent - Nasdaq
Here's Why McKesson (MCK) is a Strong Growth Stock - Yahoo Finance
Is McKesson’s 41.7% Price Surge Backed by Its Specialty Drug Expansion? - simplywall.st
Does McKesson’s 56% Rally in 2025 Leave Further Upside on the Table? - Yahoo Finance
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now? - sharewise.com
McKesson (MCK): Valuation Spotlight as Analyst Upgrades and Specialty Expansion Drive Fresh Investor Interest - simplywall.st
How McKesson Stock Gained 30% - Trefis
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic? - sharewise.com
3 Reasons Growth Investors Will Love McKesson (MCK) - sharewise.com
McKesson Settles Suit Over Workers’ Refusal to Get Covid-19 Shot - Bloomberg Law News
Argus Research Adjusts McKesson Price Target to $950 From $800, Maintains Buy Rating - MarketScreener
Iterum’s antibiotic ORLYNVAH now available through McKesson - Investing.com
McKesson Corporation (MCK) Stock Forecasts - Yahoo Finance
McKesson Corporation (MCK) Strong Quarter Spurs Analyst Confidence - MSN
McKesson stock hits all-time high at 867.9 USD By Investing.com - Investing.com Nigeria
McKesson stock hits all-time high at 867.9 USD - Investing.com India
Why McKesson Corporation stock could outperform in 20252025 Market Outlook & Daily Stock Momentum Reports - newser.com
How McKesson Corporation (MCK) stock gains from tech spendingRate Hike & Low Drawdown Investment Strategies - newser.com
Why McKesson Corporation (MCK) stock could outperform next year2025 Price Targets & Smart Money Movement Alerts - newser.com
Here's How Much $1000 Invested In McKesson 5 Years Ago Would Be Worth Today - Sahm
Can McKesson Corporation stock sustain breakout momentumQuarterly Investment Review & Low Risk Investment Opportunities - newser.com
Is McKesson Corporation stock cheap vs fundamentals2025 Top Decliners & Free High Return Stock Watch Alerts - newser.com
What market sentiment indicators show for McKesson Corporation stock - newser.com
Is McKesson Corporation stock cheap at current valuationJuly 2025 Action & Free Growth Oriented Trading Recommendations - newser.com
How McKesson Corporation (MCK) stock responds to job market shiftsEarnings Beat & Target Return Focused Stock Picks - newser.com
Is McKesson Corporation (MCK) stock worth buying before Fed actionPortfolio Return Report & Weekly High Conviction Trade Ideas - newser.com
What consensus target says about McKesson Corporation stockJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
What machine learning models say about McKesson CorporationMarket Sentiment Summary & Daily Chart Pattern Signal Reports - newser.com
Final Trades: Freeport-McMoRan, Cisco, Teradyne and McKesson Corp. - MSN
Why McKesson Corporation (MCK) stock stays on top picksGlobal Markets & Weekly Stock Breakout Alerts - newser.com
What MACD trends signal for McKesson Corporation (MCK) stockGold Moves & Safe Entry Zone Tips - newser.com
Can McKesson Corporation stock deliver consistent EPS growth2025 Short Interest & Safe Swing Trade Setup Alerts - newser.com
Finanzdaten der Mckesson Corporation-Aktie (MCK)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.38%
1.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):